A. Crowe and M. Lemaire, In vitro and in situ absorption of SDZ-RAD using a human 10 intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with 11 rapamycin, Pharmaceutical Research, vol.15, issue.11, pp.1666-72, 1998.
DOI : 10.1023/A:1011940108365

N. Picard and P. Marquet, The influence of pharmacogenetics and cofactors on clinical outcomes in kidney transplantation, Expert Opinion on Drug Metabolism & Toxicology, vol.35, issue.3, pp.731-774, 2012.
DOI : 10.1073/pnas.0506483102

URL : https://hal.archives-ouvertes.fr/inserm-00577136

D. Anglicheau, L. Corre, D. Lechaton, S. Laurent-puig, P. Kreis et al., Consequences of Genetic Polymorphisms for Sirolimus Requirements After Renal Transplant in Patients on Primary Sirolimus Therapy, American Journal of Transplantation, vol.8, issue.3, pp.595-603, 2005.
DOI : 10.1177/0091270003043006001